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Abstract
The inhibitory neurotransmitter GABA is synthesized by the enzyme glutamic acid decar-
boxylase (GAD) in neurons and in pancreatic β-cells in islets of Langerhans where it func-
tions as a paracrine and autocrine signaling molecule regulating the function of islet
endocrine cells. The localization of the two non-allelic isoforms GAD65 and GAD67 to vesic-
ular membranes is important for rapid delivery and accumulation of GABA for regulated se-
cretion. While the membrane anchoring and trafficking of GAD65 are mediated by intrinsic
hydrophobic modifications, GAD67 remains hydrophilic, and yet is targeted to vesicular
membrane pathways and synaptic clusters in neurons by both a GAD65-dependent and a
distinct GAD65-independent mechanism. Herein we have investigated the membrane as-
sociation and targeting of GAD67 and GAD65 in monolayer cultures of primary rat, human,
and mouse islets and in insulinoma cells. GAD65 is primarily detected in Golgi membranes
and in peripheral vesicles distinct from insulin vesicles in β-cells. In the absence of GAD65,
GAD67 is in contrast primarily cytosolic in β-cells; its co-expression with GAD65 is neces-
sary for targeting to Golgi membranes and vesicular compartments. Thus, the GAD65-inde-
pendent mechanism for targeting of GAD67 to synaptic vesicles in neurons is not functional
in islet β-cells. Therefore, only GAD65:GAD65 homodimers and GAD67:GAD65 heterodi-
mers, but not the GAD67:GAD67 homodimer gain access to vesicular compartments in β-
cells to facilitate rapid accumulation of newly synthesized GABA for regulated secretion and
fine tuning of GABA-signaling in islets of Langerhans.
Introduction
In mammals, two highly homologous non-allelic isoforms of the enzyme glutamate decarbox-
ylase (GAD), GAD65 and GAD67, synthesize the major inhibitory neurotransmitter GABA
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from glutamate [1, 2], thereby controlling its cellular levels. GAD and GABA are expressed in
GABA-ergic neurons in the central nervous system [1] and in insulin-producing β-cells in the
islets of Langerhans [3] where secreted GABA functions as a growth factor for cells and as a
paracrine [4, 5] and autocrine signaling molecule [5, 6] involved in regulation of hormone se-
cretion [7]. GAD67 binds the coenzyme pyridoxal 5-phosphate (PLP) tightly and is constitu-
tively active, producing ~90% of basal GABA levels in the brain. In contrast, GAD65 oscillates
between an active PLP-bound holoenzyme and an inactive apoenzyme [8, 9]. The evidence
from GAD65 and GAD67 knockout mice is consistent with a mechanism whereby GAD67
provides most of the basal levels of GABA for inhibitory neurotransmission, whereas transient-
ly activated GAD65 synthesizes GABA in response to sudden increases in GABA demand, so
as to fine-tune GABA-ergic synaptic function [10, 11]. GAD65’s unique membrane anchoring
properties and ability to rapidly cycle between synaptic vesicle membranes in axon termini and
a depot in Golgi membranes via a palmitoylation/depalmitoylation mechanism [12, 13] is likely
an integral part of the rapid GABA response mediated by GAD65 synthesis [14, 15].
GAD65 and GAD67 are highly homologous proteins, except in their N-terminal regions
that mediate distinct membrane anchoring properties of the two isoforms [2]. Both GAD65
and GAD67 are synthesized as soluble hydrophilic molecules. GAD65 undergoes a set of in-
trinsic post-translational hydrophobic modifications in the N-terminal domain [16, 17]. The
first set of hydrophobic modifications is reversible and results in a peripheral association with
the cytosolic face of ER and Golgi membranes [16–18]. This form can cycle between the cytosol
and ER/cis-Golgi membranes until a double palmitoylation of cysteines 30 and 45 [19] by the
palmitoyl transferase HIP14 [20], results in anterograde trafficking through the trans-Golgi
network to vesicular compartments and a final destination in synaptic vesicles in axon termini
[12, 18, 24]. GAD67, in contrast, remains hydrophilic [22], and instead acquires–by two differ-
ent mechanisms–the capability for membrane anchoring and trafficking to Golgi membranes,
cytosolic vesicles, and presynaptic nerve terminals in neurons. The first mechanism involves
heterodimerisation of GAD67 and GAD65 through their middle domains, and consequent
piggy-backing of GAD67 onto GAD65’s membrane trafficking pathway [22, 23]. The second
mechanism is independent of GAD65, involving the N-terminal domain of GAD67, which me-
diates piggy-backing of GAD67 onto another membrane-binding moiety [23]. The importance
of the GAD65 independent mechanism was shown by analyses of neurons of GAD65-/- mice,
which revealed that mouse GAD67 is firmly membrane anchored and efficiently transits to
presynaptic clusters in the absence of GAD65, despite lacking intrinsic hydrophobicity [22,
24]. The GAD65-independent membrane anchoring mechanism of GAD67 may explain how
GABA synthesized by GAD67 suffices for normal brain development and satisfies most re-
quirements for GABA-ergic neurotransmission in adult GAD65-/- mice.
While neurons in different parts of the brain typically express both isoforms of GAD,
human β-cells only express GAD65, mouse β-cells express GAD67, and lack detectable expres-
sion of GAD65, whereas rat β-cells express both isoforms of the enzyme [25–27]. The function-
al consequence of this inter-species variation in β-cell GAD isoform-expression is unknown.
In addition to serving as an intracellular source of fuel in β-cells [28], GABA is released
from rat β-cells by regulated Ca+2-dependent exocytosis during membrane depolarization in
response to physiological voltages [4]. Consistent with this finding, the islets of Langerhans ex-
press components required for GABA signaling. Thus, GABAA receptors are detected in α, β,
and δ-cells of human islets [29] and in α- [30] and β-cells in murine islets [31, 32]. GABAB re-
ceptors have been detected in human [29] and mouse β-cells [33] and in rat α- and β-cells [4].
Furthermore, the plasma membrane GABA transporter GAT3 is expressed in α- and β-cells
[34]. Finally, the finding that the vesicular GABA/glycine transporter VGAT is expressed at
high levels in α-cells and either low or non-detectable levels in β-cells [34–36] suggests that a
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distinct β-cell vesicular transporter is yet to be identified. The detailed mechanism of GABA
signaling through GABAA and GABAB receptors in islets and the effects on hormone secretion
is not fully clarified, and the results of independent studies are often conflicting. For instance,
while there is a general consensus that GABA secreted by β-cells inhibits glucagon secretion by
α-cells via GABAA receptors [37–39], different studies of the effect of GABA receptor signaling
on somatostatin secretion, suggest inhibition, stimulation, or no effect [29, 37, 40, 41]. GABA’s
effect on insulin secretion varies with the glucose concentration and species, and depends on
whether signaling is through GABAA or GABAB receptors. While signaling via GABAA recep-
tors is stimulatory for insulin secretion [29, 31], signaling via GABAB receptors appears to be
inhibitory [4, 5, 42].
GAD65 has distinguishing features from GAD67 that make it differentially susceptible to
becoming a target of autoimmunity in the two cell types that express it, neurons and islet β-
cells. Autoimmunity to GAD65 in β-cells is associated with β-cell destruction and development
of Type 1 diabetes [43] while autoimmunity to GAD65 in GABA-ergic neurons is associated
with development of a rare neurological disorder, Stiff Person Syndrome [44].
Although the initial studies of the hydrophobic forms and membrane anchoring of endoge-
nous GAD65 were carried out in islets of Langerhans [16, 17], the studies of the role of palmi-
toylation and subcellular trafficking, which required high resolution confocal microscopy, were
performed in neurons, for which suitable techniques were available [12, 18, 22, 23]. In order to
similarly elucidate the membrane trafficking and fate of GAD65 and GAD67 in β-cells, we
have now developed a method to grow and transfect primary cultures of islet cells in order to
study the GAD isoforms in β-cells by high-resolution confocal microscopy. This approach has
revealed that GAD65 membrane trafficking is similar to neurons, but that β-cells lack the neu-
ronal mechanism for GAD65-independent mechanism of GAD67 membrane anchoring [23].
Therefore, in β-cells, GAD67 can only be anchored to membranes by dimerization with
GAD65 and the β-cell is distinct from neurons in only expressing soluble GAD67 in the ab-
sence of GAD65.
Materials and Methods
Antibodies
The following primary antibodies were used for immunostaining of Western blots: mouse
monoclonal antibody to GFP (Covance, Richmond, CA); the 1701 rabbit polyclonal antibody,
which recognizes GAD65 and GAD67 equally well on Western blots [25]. The following pri-
mary antibodies were used in immunofluorescence experiments: chicken anti-GFP polyclonal
antibody (Millipore); mouse monoclonal antibody against the Golgi matrix protein of 130 kDa
(GM130; BD Biosciences, Palo Alto, CA); guinea pig anti-insulin polyclonal antibody (Milli-
pore); mouse monoclonal (ascites) antibody against GAD65 isoform (GAD6, a gift from
Dr. D. Gottlieb, Washington University, Saint Louis, MO, [45]; rabbit polyclonal antibody
against GAD67 isoform (K2, Millipore); a mixture of GAD65-specific human monoclonal anti-
bodies MICA 2, 3, and 6, derived from a newly diagnosed type 1 diabetic patient (a gift from
Dr. W. Richter, University of Heidelberg, Heidelberg, Germany) [46]; rabbit anti-synaptophy-
sin polyclonal antibody (Life Technologies, Carlsbad, CA); rabbit polyclonal antibody against
the Golgi marker protein giantin (Abcam, Cambridge, MA); Living Colors DsRed rabbit poly-
clonal antibody raised against DsRed-Express that recognizes mCherry (Clontech, Palo Alto,
CA); and chicken anti-calreticulin (ER lumen marker) polyclonal antibody (Abcam). A rabbit
anti-NAP22 polyclonal antibody (Millipore) was used for immunostaining of Western blots
and immunofluorescence of fixed cells. The following secondary antibodies were used in
immunofluorescence experiments: Cy3-conjugated donkey anti-mouse, anti-rabbit, or
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anti-human IgG; Cy3-conjugated goat anti-guinea pig IgG (all from Jackson ImmunoResearch
Laboratories, West Grove, PA); Cy3-conjugated goat polyclonal antibody to chicken IgY
(Abcam); Alexa Fluor 405 anti-mouse IgG; Alexa Fluor 488 goat anti-mouse, anti-rabbit, or
anti-chicken IgG; Alexa Fluor 568 goat anti-rabbit; Alexa Fluor 633 goat anti-chicken IgG (all
from Life Technologies).
Islet and neuron isolation, cell culture, and transfection
Neonatal rat islets were isolated from 4–5-days-old Sprague Dawley rat pups (Charles River,
Wilmington, MA) as previously described [47] except using collagenase P (Roche Diagnostics,
Indianapolis, IN) digestion and Histopaque 1119 (Sigma Aldrich, St. Louis, MO) density gradi-
ent purification. Mouse islets were isolated from 3–5-weeks-old C57BL/6 mice (Charles River),
as previously described [48]. Human islets were obtained from the European Center for Islet
Transplantation (ECIT) Islets for Basic Research Program. Isolated islets were pre-cultured at
37°C in 5% CO2 for 1–2 days in RPMI 1640 medium supplemented with glutamax, 100 U/ml
penicillin, 100 μg/ml streptomycin, and 10 mMHEPES (all from Life Technologies). Islets
were hand-picked, washed once with Ca2+/Mg2+-free Hank’s BSS, and dispersed into single
cells by a brief incubation with 0.05% trypsin-EDTA in a Ca2+/Mg2+-free medium using a mild
mechanical disruption. The dispersed islet cells were seeded (25,000–30,000 cells/well) on cov-
erslips coated with extracellular matrix (ECM) in four-well culture plates (Biological Industries,
Kibbutz Beit Haemek, Israel) in RPMI-1640 medium supplemented with glutamax, 2% human
serum (Lonza, Walkersville, MD), 100 U/ml penicillin, 100 μg/ml streptomycin, and 10 mM
HEPES. The single cells were allowed to adhere for 3–5 days before experiments. Single islet
cells were transfected for 5 h with either Lipofectamine 2000 or Lipofectamine Plus reagents ac-
cording to the manufacturer’s instructions (Life Technologies) with similar transfection effi-
ciency of ~0.1% (~25 transfected cells/25,000 cells). For indirect immunofluorescence analysis,
cells were fixed 24–48 h after transfection with 4% paraformaldehyde (EM grade; Electron Mi-
croscopy Sciences, Hatfield, PA). Rat insulinoma INS-1 cells [49] and mouse insulinoma
MIN6 cells [50] were obtained from Dr. John Hutton (Barbara Davis Diabetes Center, Denver,
Colorado) and cultured in RPMI 1640 medium and DMEMmedium respectively with high
glucose (25 mM glucose). For indirect immunofluorescence analysis, cells were cultured on
glass coverslips coated with poly-D-lysine and fibronectin in 24-well plates. INS-1 and MIN6
cells were transfected for 5 h with Lipofectamine Plus reagent according to the manufacturer’s
instructions (Life Technologies) with a transfection efficiency of ~40%.
Primary hippocampal neuronal cultures were prepared from either embryonic day 18/19
rats [51] or postnatal day 2/3 rats [52]. Neurons, COS-7, and CHO-K1 cells were cultured and
transfected as described earlier [23]. For indirect immunofluorescence analysis, hippocampal
neurons, COS-7, and CHO-K1 cells were cultured on glass coverslips coated with either poly-
D-lysine or poly-L-ornithine (P2/3 neurons) in 24-well plates. Hippocampal neurons were
transfected at day-in-vitro 6–7 using Effectene transfection reagent (QIAGEN, Maryland, MD)
with transfection efficiency of ~1%. After 2–3 h of incubation at 37°C, the transfection solution
was replaced with a 50:50 solution of fresh/conditioned medium. COS-7 and CHO-K1 cells
were transfected using Lipofectamine 2000 reagent (Life Technologies) for 5 h at 37°C with a
transfection efficiency of ~60%.
DNA constructs
As described in detail earlier, the C-terminal fusion proteins of EGFP and mouse, rat, or
human GAD67 were generated by PCR using mouse, human, or rat GAD67 in pSV-SPORT as
templates. The PCR products were subcloned into the HindIII and KpnI sites in-frame with
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EGFP in pEGFP-N3 (Clontech, Palo Alto, CA) [23]. The mouse, rat, and human GAD67-GFP
proteins have been shown to share similar characteristics including membrane association and
subcellular distribution in neurons [23]. The construction of the C-terminal fusion protein of
EGFP and human GAD65 (hGAD65-GFP) was described previously [18]. The construction of
the mammalian expression vector containing mCherry–tagged human GAD65 fusion protein
(hGAD65-mCherry) was described previously [23].
Immunofluorescence analyses
Immunofluorescence analysis of primary rat hippocampal neurons, COS-7, CHO, INS-1, and
MIN6 cells was performed as described previously [23]. Mouse and rat islet single cells were
fixed with 4% paraformaldehyde for 30 min and then permeabilized for 1 h with permeabiliza-
tion buffer (PBS containing 0.5% Triton X-100 and 0.2% bovine serum albumin). Cells were
blocked using animal-free blocker (Vector, Burlingame, CA) diluted 5-fold with water for 30
min and incubated with primary antibodies in permeabilization solution for 2 h. Cells were in-
cubated with the respective secondary antibodies in permeabilization solution for 1 h with gen-
tle shaking. To stain the nuclei, cells were incubated with the nuclear stain Hoechst 333432 (10
μg/ml in PBS) for 15 min. The coverslips were mounted in Prolong Gold antifade reagent (Life
Technologies). The images were captured using a Leica TCS SP2 or SP5 laser scanning confocal
fluorescence microscopes equipped with acousto-optical beam splitters and an HCX Plan-
Apochromat 63x/1.20 NA oil objective. Images of 8-bit depth were collected using the Leica
confocal software. All confocal images represent projections derived from 8–10 consecutive
horizontal optical sections estimated at 0.5–1 μm in thickness. Final brightness/contrast picture
adjustment and layout of the figures were done using Photoshop software (Adobe Systems, San
Jose, CA).
A co-localization analysis of GAD67-GFP with GAD65-mCherry or the Golgi marker
GM130 and of endogenous GAD67 with endogenous GAD65 or the Golgi marker GM130 was
performed on projected confocal images using the correlation plot application in MetaMorph
software (Universal Imaging, Sunnyvale, CA). A second set of co-localization analysis was per-
formed on GAD65-GFP or endogenous GAD65 with the Golgi markers GM130 and giantin,
or insulin. When measuring the co-localization with Golgi marker, the Golgi marker with red
fluorescence was designated as the region of interest during the analysis and then this image
was thresholded prior to the measurement, so that only pixels that have intensities that are out-
side of the threshold range were excluded from the measurement. When measuring the co-lo-
calization with cytosolic vesicles, the whole cell image was designated as the region of interest
during the analysis. The calculation of the correlation coefficient by MetaMorph was described
previously [12]. All data represented as mean ± SEM. To establish significance, results of quan-
tification were analyzed by unpaired Student’s t-test using a two-tailed distribution and two-
sample equal variance. The statistical analysis was performed using GraphPad Prism version
4.0 (GraphPad Software, San Diego, CA).
Subcellular fractionation
Subcellular fractionation of INS-1 cells transiently expressing GAD67-GFP or GAD65-GFP,
and mouse and rat islets was carried out as described previously [22]. Mouse islets were isolated
from twenty 5-weeks-old C57BL/6 mice and rat islets were isolated from twenty 7-days-old
Sprague Dawley rat pups. After 48 h of pre-culture, approximately 3000 islets were hand-pick-
ed again, washed once with 10 ml of ice-cold Ca2+/Mg2+-free Dulbecco’s phosphate buffered
saline (DPBS) (Life Technologies), homogenized on ice for 20 min using a glass homogenizer,
and subjected to subcellular fractionation as described above.
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Western blot analysis
Proteins were separated by SDS/PAGE on 10% NuPAGE Novex Bis-Tris mini gels (Life Tech-
nologies) and electroblotted onto nitrocellulose membranes. After the transfer, membranes
were blocked with TBST (20 mM Tris/HCl, pH 7.5, 150 mMNaCl and 0.1% Tween 20) con-
taining 10% non-fat dried skimmed milk powder for 1 h at room temperature. The filter mem-
branes were then incubated for 1 h at room temperature with primary antibodies diluted in
TBST containing 5% nonfat dry milk. The 1701 rabbit polyclonal antibody was used at 1:5,000
dilution, the mouse monoclonal antibody to GFP was used at 1:20,000 dilution, and the
NAP22 antibody was used at 1:1000 dilution. Membranes were washed with TBST and then in-
cubated for 1 h at room temperature with secondary horseradish peroxidase (HRP)-coupled
sheep anti-mouse IgG or donkey anti-rabbit IgG (GE Healthcare, Buckinghamshire, UK) at
1:40,000 dilution in TBST containing 5% nonfat dry milk. The blots were developed using
SuperSignal West Femto Maximum Sensitivity Chemiluminiscent Substrate (Thermo Scientif-
ic, Rockford, IL) and visualized on Hyperfilm ECL X-ray films (GE Healthcare). Scanning of
autoradiograms was performed using EPSON Perfection 1200U scanner. For densitometry
analysis, the band intensity of GAD65 and GAD67 were quantified by calculating the area
under the curve of the specific signal using ImageJ software (NIH, Bethesda, MD). Immunos-
taining with the NAP22 antibody, was followed by incubation with an IRDye labeled anti-IgG
secondary antibody (Odyssey, LI-COR, Lincoln, NE) at 1:15,000 dilution and imaged with an
Odyssey Infrared Imager (LI-COR).
Ethics Statement
Human islets for research were received from the University Hospital of Geneva thanks to the
European Consortium for Islet Transplantation (ECIT) through islet distribution network
(http://ecit.dri-sanraffaele.org/en/login/index.html) and analyzed at École Polytechnique
Fédérale de Lausanne (EPFL). The use of human islet preparations for experimental research
through ECIT was approved by the Institutional Review Board for clinical research of the De-
partments of Neurology, Dermatology, Anesthesiology and Surgery of the University Hospital
of Geneva (CER Nr. 05–028). The University of Geneva Ethical Board waived the need for a
consent from donors because islets were used for experimental research only when not suitable
for clinical purposes and would otherwise have been destined for destruction. In such cases, ob-
taining informed consent is not mandatory in Switzerland. While EPFL does not have an insti-
tutional review board for research using human material, permit is granted for its use as long
as the provider can certify that the samples were obtained according to local laws, regulations,
and good practices. The study of rat and mouse islets and rat neurons was approved by the in-
stitutional review boards for the University of California San Francisco (UCSF), École Poly-
technique Fédérale de Lausanne (EPFL), and University of Copenhagen. The numbers of the
IACUC ethical approvals were for UCSF: AN083181 and AN091704, for EPFL: 2567, and for
University of Copenhagen: 2008/561–1515.
Results
INS-1 and MIN6 insulinoma cells lack the GAD65 independent
mechanism for membrane anchoring and targeting of GAD67 to
membrane compartments
Transfected GAD67-GFP is efficiently targeted to Golgi membranes, somatic vesicles, and pre-
synaptic nerve terminals in neurons independent of GAD65 [23] (S1 Fig.). We assessed wheth-
er GAD67-GFP and GAD65-GFP similarly acquire membrane anchoring in the insulinoma
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cell lines, INS-1 and MIN6, which lack the expression of endogenous GAD65 and GAD67
proteins. Confocal analyses of INS-1 and MIN6 cells, singly transfected with mGAD67-GFP re-
vealed that, in contrast to neurons and several non-neuronal cell lines [23] (S1 Fig.), GAD67-
GFP does not concentrate in the Golgi compartment or in cytosolic vesicles in the absence of
GAD65, and is instead detected in a diffuse uniform pattern in the cytosol of insulinoma cells
(Fig. 1A and B). In contrast, transfected hGAD65-GFP was concentrated in the Golgi compart-
ment, where it colocalized with the Golgi marker GM130, and in cytosolic vesicles (Fig. 1C-E)
distinct from insulin-containing secretory granules (S2 Fig.). These results suggest that, in con-
trast to neurons and some non-neuronal cell lines, the GAD65-independent membrane an-
choring machinery is missing in INS-1 and MIN6 cells.
Subcellular fractionation analyses of brains from GAD65-/- mice have shown that about half
of endogenous neuronal GAD67 is firmly membrane anchored in the absence of GAD65 [22].
Similar results were obtained in COS-7 cells singly transfected with mouse or human GAD67
[23]. These results are consistent with confocal analysis showing targeting of GAD67-GFP to
membrane compartments in neurons and several cell lines in the absence of GAD65 [23] (S1
Fig.). While the confocal analyses of GAD67-GFP in INS-1 and MIN6 cell lines showed a uni-
form cytosolic pattern, it did not exclude that a fraction of the protein was anchored to Golgi
membranes (Fig. 1, panels A, B, overlay). To assess whether a fraction of GAD67-GFP was
membrane anchored in these cells, INS-1 cells singly transfected with rat, mouse, or human
GAD67-GFP, were subjected to subcellular fractionation. The results were compared to the
subcellular distribution of singly transfected hGAD65 (Fig. 2). We used a hypotonic homogeni-
zation buffer containing 1mMMgCl2, which releases most of the hydrophobic peripheral
weakly membrane associated form of GAD65 into the cytosolic fraction [17]. Membranes were
washed twice in a high salt solution (0.5 M NaCl), first to remove traces of cytosolic proteins,
and then any remaining peripheral membrane-associated proteins, before extraction of firmly
membrane-anchored proteins with detergent [16, 17]. Analysis of post-nuclear subcellular
fractions (Fig. 2) revealed that singly transfected GAD67-GFP in INS-1 cells is primarily de-
tected in the cytosolic and first membrane wash fractions (Fig. 2A-C, E). In contrast, about half
of singly transfected hGAD65-GFP in INS-1 cells was detected in washed membrane fractions
(Fig. 2D and E). These experiments provide additional evidence that INS-1 cells lack the
GAD65-independent membrane anchoring mechanism of GAD67.
Endogenous GAD65 and transfected GAD65-GFP target to Golgi and
vesicular membrane compartments in primary β-cells
INS-1 and MIN6 cells have lost the expression of endogenous GAD65 and GAD67, and may
also have lost expression of components required for aspects of membrane anchoring and traf-
ficking of the GAD isoforms. To study the subcellular localization of GAD65 and GAD67 in
primary β-cells, we developed monolayer cultures of dispersed islet cells prepared from rat,
mouse, or human islets and grown on cover slips. We first analyzed the distribution of endoge-
nous GAD65 in monolayer cultures of rat islets cells, immunostained for GAD65, the Golgi
marker protein giantin, and insulin. Fig. 3, panels A and B show representative results of three
Fig 1. In the absence of GAD65, GAD67-GFP is cytosolic in INS-1 andMIN6 cells. Projected confocal images of INS-1 cells (A, C), and MIN6 cells (B, D)
transiently expressing either mGAD67-GFP (A, B) or hGAD65-GFP (C, D). Cells were fixed 24 h following transfection and then immunostained for GFP
(green) and the Golgi marker GM130 (red) before confocal analyses. GAD67-GFP is detected in an even diffuse pattern throughout the cytosol of INS-1 and
MIN6 cells and does not appear to concentrate in the Golgi (red) or vesicular membrane compartments (A, B, enlarged frames). In contrast, hGAD65-GFP is
detected in the Golgi compartment and in vesicular compartments in INS-1 and MIN6 cells (C, D; enlarged frames). Scale bar: 10 μm. (E) Correlation
coefficient analysis for co-localization of GAD67-GFP and GAD65-GFP with GM130 in INS-1 and MIN6 cells. Results are presented as mean ± S.E. for 15
cells for each protein in INS-1 cells and for 6 cells for each protein in MIN6 cells. **P< 0.002; ***P< 0.0001
doi:10.1371/journal.pone.0117130.g001
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Fig 2. In the absence of GAD65, subcellular fractionation of INS-1 cells reveals lack of membrane
targeting of GAD67-GFP. Immunoblotting analysis of the subcellular distribution of rat, mouse, and human
GAD67-GFP in INS-1 cells (A-C), and human GAD65-GFP in INS-1 cells (D). INS-1 cells expressing either
recombinant GAD67-GFP or GAD65-GFP proteins were subjected to subcellular fractionation using
homogenization conditions that release most of the hydrophobic weakly membrane associated form of
GAD65 into the soluble cytosolic fraction. Postnuclear supernatants were separated into a cytosolic fraction
(lane 1), proteins washed frommembranes by high salt (0.5 M NaCl, lanes 2 and 3), and firmly membrane
anchored proteins extracted with 1% TX-114 (lane 4) were subjected to SDS-PAGE and immunoblotting with
mouse anti-GFP antibodies. (E) Quantitative analysis of the subcellular distribution of GAD67-GFP and
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different independent experiments in rat islet cells. Endogenous GAD65 was expressed in both
the Golgi compartment and in vesicles distinct from insulin containing vesicles (Fig. 3A, B, E)
as shown in INS-1 cells (S2 Fig.). A similar pattern of expression of endogenous GAD65 was
also observed in monolayers of human islets (S3 Fig.) and in intact rat and human islets in cul-
ture. We observed that in the cultures of neonatal rat islet cells, a fraction (approximately 20%)
of cells positive for insulin staining did not express endogenous GAD65 at detectable levels (see
cells indicated with arrow heads in Fig. 3A and S4 Fig.). This is in contrast to the situation in
adult rat islets [28] and adult human islet cells where every insulin positive cell also expresses
GAD65 and suggests that insulin expression may precede GAD65 expression in newly differ-
entiated β-cells in neonatal rat islets. We were unable to detect GAD65 expression in any insu-
lin negative cells including glucagon positive α-cells (S4 Fig.). A similar pattern of expression
was observed when single cells from neonatal rat islets were transfected with hGAD65-GFP.
Fig. 3, panels C, D, E show representative results of four independent experiments. Notably,
hGAD65-GFP expresses either entirely in the Golgi compartment in some cells (not shown), in
both Golgi and cytosolic vesicles (Fig. 3C), or entirely in vesicles (Fig. 3D). The variations from
cell to cell in the ratio between Golgi versus cytosolic expression of GAD65-GFP were consis-
tent with observations in INS-1 and MIN6 cells (Fig. 1) and of endogenous GAD65 expression
in rat and human islet cells (Fig. 3B and results not shown).
Singly expressed endogenous GAD67 in islet β-cells is cytosolic, while
GAD67 in β-cells expressing GAD65 is targeted to Golgi and vesicular
membrane compartments
To address the possibility that primary β-cells have preserved the GAD65 independent mecha-
nism of membrane anchoring of GAD67, we exploited the intrinsic differences in GAD65 ex-
pression between mouse and rat islet β-cells, comparatively analyzing the expression of
endogenous GAD67 in primary cultures of mouse islet cells that lack detectable expression of
GAD65 and in rat islet cells that express both isoforms of GAD [25, 53]. As expected, high-res-
olution confocal analysis revealed no signal for endogenous GAD65 in any of the mouse islet
β-cells (Fig. 4A). In these GAD65-deficient cells, endogenous mouse GAD67 was absent from
Golgi membranes and cytosolic vesicles and instead appeared evenly distributed in the cytosol
(Fig. 4A, E). In contrast, in rat islet single cells, endogenous GAD67 and GAD65 co-localized
in Golgi membranes (Fig. 4B-F) and in vesicular compartments (Fig. 4B, enlarged frame, 4F).
Finally, to study the targeting of GAD67-GFP in the absence of GAD65 in primary rat islet
cells, neonatal rat islet cells were singly transfected with mGAD67-GFP followed by immunos-
taining of fixed cells for GFP, endogenous GAD65, and the Golgi marker protein GM130. We
identified transfected islet cells that were negative for endogenous GAD65, and are therefore ei-
ther GAD65-negative beta cells, such as those shown in Fig. 3A, or islet non-β-cells. mGAD67-
GFP in GAD65 negative rat islet cells was not targeted to Golgi membranes or cytosolic vesi-
cles, and instead was evenly distributed in the cytosol (Fig. 4D, E). Thus GAD67 in islet cells
appears to only target to membrane compartments when co-expressed with GAD65.
GAD65-GFP in INS-1 cells. Quantitation of GAD-GFP is expressed as the percentage of total GAD. Data are
presented as mean ± S.E., n = 3. While GAD65-GFP expressed in INS-1 cells is equally distributed between
the cytosol (45.3 ± 3.8%) and firmly membrane bound (48.7 ± 2.3%) fractions, most of GAD67-GFP in INS-1
cells is distributed in the cytosol (79.9 ± 6.6%) and first membrane wash (17.7 ± 5.9%). Thus, while human
GAD65-GFP is equally distributed between the cytosol fraction and in the washed membrane fraction,
GAD67-GFP transiently expressed in INS-cells is primarily detected in the cytosol and the first membrane
wash fractions in the absence of GAD65.
doi:10.1371/journal.pone.0117130.g002
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As shown in Figs. 1 and 2, singly transfected GAD67-GFP was detected in a diffuse cytosolic
pattern and>90% is localized in the cytosol fraction of the insulinoma cell lines INS-1 and
MIN6. However, the appearance of endogenous GAD67 in mouse islet cells (Fig. 4A) was less
diffuse in appearance in confocal images than GAD67-GFP in insulinoma cells (Fig. 1A, B). To
further study the subcellular localization of endogenous GAD67 in the absence and presence of
endogenous GAD65, mouse and rat islets were subjected to subcellular fractionation analysis
followed by SDS-PAGE andWestern blotting with the 1701 rabbit polyclonal antibody that
recognizes GAD65 and GAD67 with similar affinity. Subcellular distribution analysis revealed
that in the absence of GAD65 in mouse islets, GAD67 is about equally distributed between the
cytosol and first membrane wash fractions (Fig. 5A, lanes 1 and 2), and is completely absent
from the firmly membrane-anchored protein fraction extracted from washed membranes by
detergent (Fig. 5, lane 4). However, in rat islets, the majority of GAD67 is detected together
with GAD65 in the firmly membrane anchored protein fraction (Fig. 5A, lane 8). Taken to-
gether, the results provide evidence that mouse β-cells lack the GAD65-independent machin-
ery for membrane anchoring and trafficking of GAD67 through membrane compartments to
reach peripheral vesicles. However, the increased amount of GAD67 distributed into the first
membrane wash as well as the confocal appearance of the protein in an extensive cytosolic net-
work suggest that mouse islet cells may differ from insulinoma cells in having the ability to me-
diate weak reversible peripheral membrane association of GAD67. The results also suggest that
the presence of GAD65 in rat islet cells results in membrane anchoring and targeting of
GAD67 to the Golgi compartment and vesicular compartments. Thus, similar to the situation
in primary rat hippocampal neurons [22, 23], we propose that GAD67 in β-cells piggy-backs
onto the membrane anchoring and trafficking pathway of GAD65 through heterodimerization.
In primary pancreatic β-cells and in insulinoma cells, transiently
expressed GAD67-GFP traffics to Golgi membranes and vesicular
compartments via its association with GAD65-mCherry
The results described above do not directly show that expression of GAD65 in rat islet cells me-
diates targeting of GAD67 to membrane compartments. To further assess the role of GAD65
expression on GAD67 membrane anchoring and targeting, we transfected GAD67-GFP into
primary mouse and rat islet cells and insulinoma cells either singly or together with GAD65-
mCherry. The mCherry construct encodes a protein that has previously been shown to target
to Golgi membranes, cytosolic vesicles, and presynaptic nerve terminals in rat hippocampal
neurons, similarly to endogenous GAD65 [23]. The subcellular localization of transfected
GAD65-mCherry and GAD67-GFP in islet and insulinoma cell cultures was studied using
high-resolution confocal analyses. While singly transfected hGAD65-mCherry was targeted to
Golgi membranes and peripheral vesicles in mouse islet cells (results not shown), singly trans-
fected mGAD67-GFP was absent from Golgi membranes and vesicular compartments and in-
stead distributed evenly in a cytosolic network (Fig. 6A) similar to the expression of
endogenous GAD67 in mouse islet cells (Fig. 4A). In contrast, when mGAD67-GFP was co-
expressed with hGAD65-mCherry in mouse islet-derived single cells, it was targeted to Golgi
Fig 3. Endogenous GAD65 and transfected GAD65-GFP in rat pancreatic β-cells are primarily targeted to Golgi and vesicular membrane
compartments. Projected confocal images of endogenous GAD65 (A, B) and transfected hGAD65-GFP (C, D) in rat islet single cells. Cells in panels A and
B were immunostained for endogenous GAD65 (GAD6 antibody, green), the Golgi marker giantin (red), and insulin (blue). Cells in panels C and D were fixed
48 hours following transfection and immunostained for GFP (green), the Golgi marker GM130 (red), and insulin (blue). Endogenous GAD65 and transfected
hGAD65-GFP are expressed in the Golgi compartment of rat pancreatic β-cells (A and C, enlarged frames), and in cytosolic vesicles that are distinct from the
insulin-containing vesicles (B and D, enlarged frames). Scale bar: 10 μm. (E) Correlation coefficient analysis for co-localization of endogenous GAD65 or
transfected hGAD65-GFP with either giantin/GM130 or insulin. Results are presented as mean ± S.E. n = 6–24 cells per group. ***P< 0.0001.
doi:10.1371/journal.pone.0117130.g003
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Fig 4. Confocal analyses of endogenous GAD67 and GAD65 in mouse and rat islet single cells reveal that GAD67 is cytosolic in the absence of
GAD65 but targets to Golgi and vesicular membranes in the presence of GAD65. Projected confocal images of mouse (A) and rat (B, C, D) islet single
cells immunostained for endogenous GAD67 (green, K2 rabbit polyclonal antibody), or transfected GAD67-GFP (green, antibody to GFP) and endogenous
GAD65 (red, humanmonoclonal antibodies MICA 2, 3, and 6), the Golgi marker protein GM130 (purple), and the nuclear stain Hoechst 333432 (blue). (A)
Mouse islet single cells express the GAD67 isoform and lack the expression of detectable levels of endogenous GAD65. In these GAD65-deficient cells,
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membranes (Fig. 6B) and vesicular compartments (Fig. 6C, enlarged frame a), where it coloca-
lized with hGAD65-mCherry.
Finally, we addressed the question whether GAD65-mCherry can target cytosolic
mGAD67-GFP to Golgi membranes and cytosolic vesicles in INS-1 cells. High-resolution con-
focal analyses revealed that, in contrast to the cytosolic distribution of singly transfected
mGAD67-GFP in INS-1 cells (Fig. 7A), co-transfection with hGAD65-mCherry resulted in tar-
geting of mGAD67-GFP to Golgi membranes, where it co-localized with hGAD65-mCherry
and the Golgi marker protein GM130 (Fig. 7B, F, G) and to cytosolic vesicles that also harbor
hGAD65-mCherry (confocal stacks, Fig. 7C-G). The results in transfected primary mouse β-
cells, rat islet cells, and insulinoma cells, collectively provide strong evidence that the GAD65-
independent mechanism of GAD67 membrane anchoring is lacking in islet and insulinoma
cells. Despite differing in their expression of GAD65, which resulted in Golgi trafficking of
GAD67 by piggybacking with GAD65 in rat but not mouse islets, neither rat or mouse islets ev-
idenced a GAD65-independent mechanism for GAD67 transport. Furthermore, GAD65 ex-
pression is sufficient to mediate membrane anchoring of GAD67 and targeting to Golgi
membranes and cytosolic vesicles in both mouse and rat β-cells. Thus, the GAD65-dependent
mechanism of GAD67 membrane anchoring is shared between neurons and β-cells, whereas
the GAD65-independent mechanism for GAD67 is lacking in the insulin-producing islet cells.
Both GAD67 and GAD65 were amongst several proteins identified in a pull-down assay of
rat brain extracts using a neuron enriched lipid raft protein NAP22 as a bait. Based on this re-
sult, the NAP22 protein was suggested to play a role in targeting of the GAD isoforms to mem-
branes [57]. While the membrane anchoring of GAD65 is similar in β-cells, INS-1 cells, and
neurons and seems to be independent of association with other proteins, as shown here and in
other studies [12, 13, 16–19, 21], membrane anchoring mechanism for the hydrophilic GAD67
protein in the absence of GAD65 appears to involve association with a distinct hydrophobic
membrane protein or membrane anchoring complex [23]. We addressed the question whether
the lack of the GAD65 independent membrane anchoring mechanisms for GAD67 in β-cells is
associated with a lack of NAP22 expression in islet β-cells and INS-1 cells. Immunostaining of
Western blots of islets and INS-1 cells, however, revealed that NAP22 is expressed in both cell
types, albeit at lower levels than in brain extracts (S5 Fig.). Confocal analyses of expression and
subcellular distribution of NAP22 in INS-1 cells and primary islet cells confirmed that NAP22
is expressed in insulinoma cells and in islet β- as well as non β-cells. In those cells, NAP22 is
primarily localized in the plasma membrane where GAD65 and GAD67 are absent (S6A–B
Fig.). There was no clear colocalization between singly transfected GAD67-GFP and NAP22 in
INS1 cells or between endogenous GAD65 and NAP22 in primary rat islet cells. In neurons,
colocalization of GAD65 with NAP22 was only detected in a small fraction of axonal clusters
(S6C Fig.). These results suggest that the lack of GAD67 membrane association in β cells can-
not be explained by a lack of NAP22 expression and that a possible association between
NAP22 and the GAD isoforms is either rare or non-existent in β cells. In sum, a critical role of
protein(s) distinct from NAP22 is inferred in membrane anchoring of GAD67.
endogenous mouse GAD67 is detected as a cytosolic protein and is absent from Golgi membranes and cytosolic vesicles (A, enlarged frame). Thus, mouse
islet β-cells lack the GAD65-independent machinery for trafficking GAD67 through membrane compartments to reach peripheral vesicles. (B, C) Rat islet β-
cells, however, express both the endogenous GAD67 and GAD65 isoforms. In these cells, GAD67 and GAD65 are expressed similarly in Golgi membranes
and cytosolic vesicles (B, arrowheads in enlarged frame). (D) In the subpopulation of rat islet single cells that are devoid of endogenous GAD65, transfected
mGAD67-GFP shows a cytosolic distribution and fails to associate with Golgi membranes and cytosolic vesicles (D, enlarged frame). Scale bar: 10 μm. (E)
Correlation coefficient analysis for co-localization of endogenous GAD67 or transfected GAD67-GFP with GM130 in mouse and rat islet single cells. (F)
Correlation coefficient analysis for the co-localization of endogenous GAD67 with endogenous GAD65 in the Golgi region and cytosolic vesicles in rat islet
single cells. Results are presented as mean ± S.E. n = 5–15 cells per group. ***P< 0.0001.
doi:10.1371/journal.pone.0117130.g004
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Fig 5. Subcellular fractionation of mouse and rat islets reveals lack of membrane anchoring of endogenous GAD67 in the absence of GAD65. (A)
Western-blot analysis of the subcellular distribution of endogenous GAD67 in the absence of endogenous GAD65 in mouse islets (lanes 1–4) as compared
to its distribution in the presence of GAD65 in rat islets (lanes 5–8). Mouse and rat islets were subjected to subcellular fractionation. Cytosolic proteins (lanes
1 and 5), proteins washed frommembranes by high salt (lanes 2–3 and 6–7), and detergent extracted membrane proteins (lanes 4 and 8) were subjected to
SDS-PAGE and immunoblotting with the 1701 antibody, which recognizes both GAD65 and GAD67. (B) Quantitative analysis of the subcellular distribution
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Discussion
We have previously shown in neurons, that the hydrophilic GAD67 isoform is anchored to
membranes and robustly targeted to the Golgi compartment and presynaptic clusters either by
association with the hydrophobic GAD65 isoform [22, 54] or by a distinct GAD65-indepen-
dent mechanism that involves association with a different membrane-anchoring moiety [23].
In the current study, we have analyzed the membrane anchoring and subcellular destination
of the two isoforms of GAD in pancreatic islet β-cells. The results presented here confirm that
the smaller isoform, GAD65, is targeted to the Golgi compartment and peripheral vesicles in
islet and insulinoma cells, similarly to the situation in neurons. In marked contrast, the larger
isoform–GAD67–is completely dependent on GAD65 for targeting to membrane compart-
ments in islet β-cells. As such, β-cells lack the GAD65-independent membrane anchoring
mechanism for GAD67, which was identified in neurons and some non-neuronal cell lines
[23]. Endogenous GAD67 is targeted to the Golgi compartment and peripheral secretory vesi-
cles and is firmly membrane anchored in the presence of endogenous GAD65 in rat β-cells.
Moreover, GAD65-mCherry targets GAD67-GFP to Golgi membranes and cytosolic vesicles
in insulinoma cells and GAD65-deficient mouse β-cells or rat islet cells. Therefore, the
GAD65-dependent, but not the GAD65-independent mechanism for targeting of GAD67 to
membrane trafficking pathways, is functional in β-cells.
Notably, and in agreement with the ground-breaking studies by Sorenson et al., [28], GAD65-
and GAD65/GAD67-positive vesicles in β-cells are distinct from insulin-containing vesicles and
do not colocalize with the hormone. This result is consistent with an earlier immuno-EM study
showing localization of GAD65 in Golgi membranes and membranes of small vesicles in β-cells
but not in the large dense core vesicles (LDCV) that contain insulin [17]. However, GABA, the
product of GAD65/67, has been detected in LDCVs in β-cells, suggesting that GABA released by
GADs into the cytosol of β-cells can be incorporated into LDCVs [7, 34]. Furthermore, the detec-
tion of GABA in pancreatic islet cells may indicate that GABA released into the islet interstitium
by β cells can be taken up by α-cells, perhaps by a reverse action of the plasma membrane GABA
transporter GAT3 expressed in these cells [34].
The native forms of the GAD enzymes involve non-disulfide linked dimers [8, 9, 55]. GAD
forms three distinct dimers: a GAD65:GAD65 homodimer, a GAD67:GAD65 heterodimer,
and a GAD67:GAD67 homodimer (Fig. 8). In neurons, all three dimers become targeted to
Golgi membranes, to an axonal vesicular pathway, and to presynaptic clusters [18, 23]. In addi-
tion, axonal polarization and presynaptic clustering of all three dimers are mediated by the
Rab5a-dependent pathway [24]. In pancreatic islet β-cells, however, only the GAD65:GAD65
homodimer and the GAD67:GAD65 heterodimer become targeted to Golgi membranes and
cytosolic vesicles, while the GAD67:GAD67 homodimer is predominantly a soluble cytosolic
protein. Each dimer has unique properties in terms of regulation of enzymatic activity and sub-
cellular distribution. Thus, the GAD65 homodimer is either in the apo- or holo-enzyme form,
depending on PLP levels, and serves to provide a dynamic enzyme reservoir that can rapidly be
mobilized from the Golgi compartment for trafficking to presynaptic vesicles in axon termini
in neurons and to peripheral secretory vesicles in β-cells, via the palmitoylation/depalmitoyla-
tion cycle of GAD65 [12]. The association of this dimer with a vesicular GABA transporter
of endogenous GAD67 and GAD65 in mouse and rat islets. Quantitation of the immunoblots was performed using NIH ImageJ software. GAD
immunoreactivity in each fraction is expressed as the percentage of total GAD. Data are presented as mean ± S.E. (n = 3). In the absence of GAD65 in
mouse islets, GAD67 is detected similarly in the cytosol (45.9 ± 2.7%) and first membrane wash (54.1 ± 2.7%) and is completely absent in the membrane
fraction. However, in the presence of GAD65 in rat islets, a large percentage of GAD67 (57.7 ± 4.0%) is detected together with GAD65 (71.7 ± 6.9%) in the
washed membrane fraction.
doi:10.1371/journal.pone.0117130.g005
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Fig 6. Targeting of mGAD67-GFP to Golgi and vesicular membrane compartments in GAD65 deficient mouse islet cells by co-expression with
hGAD65-mCherry. Projected confocal images of mouse islet cells singly transfected with mGAD67-GFP (A) or doubly transfected with mGAD67-GFP and
hGAD65-mCherry (B, C). Cells were fixed 48 h following transfection and immunostained for GFP (green) and the nuclear stain Hoechst 333432 (blue) (A, B,
C) and mCherry (red) (B, C). Singly transfected mGAD67-GFP shows a cytosolic distribution and does not associate with Golgi membranes and cytosolic
vesicles. However, co-expression with hGAD65-mCherry results in the targeting of mGAD67-GFP to Golgi membranes (B) and cytosolic vesicles (C,
enlarged frame a) where it colocalizes with hGAD65-mCherry. Scale bar: 10 μm. (D) Correlation coefficient analysis for co-localization of mGAD67-GFP with
hGAD65-mCherry in the Golgi region and cytosolic vesicles of doubly transfected mouse islet single cells. Results are presented as mean ± S.E. for 9 cells
analyzed for co-localization in Golgi region and 12 cells analyzed for co-localization in cytosolic vesicles.
doi:10.1371/journal.pone.0117130.g006
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Fig 7. HumanGAD65-mCherry targets mouse GAD67-GFP to cytosolic vesicles and Golgi membranes in INS-1 cells. (A) Projected confocal images
of INS-1 cell singly transfected with mGAD67-GFP and immunostained for GFP (green) and the Golgi marker GM130 (red). (B) Projected confocal images of
INS-1 cells transfected with mGAD67-GFP and hGAD65-mCherry and triple immunostained for GFP, mCherry, and GM130. (C-E) selected confocal stacks
(~0.5 μm in thickness) of INS-1 cells co-expressing mGAD67-GFP and hGAD65-mCherry and immunostained for GFP and mCherry. Co-expression with
hGAD65-mCherry results in targeting of cytosolic mGAD67-GFP (A) to Golgi membranes where it co-localizes with hGAD65-mCherry and GM130 (white
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(VGAT) on the cytosolic face of synaptic vesicle membranes in neurons [56] and either VGAT
or a distinct vesicular GABA transporter in β-cells [36] may facilitate a rapid vesicular accumu-
lation of GABA.
The GAD65:GAD67 heterodimer combines the property of a constitutively active GAD67
monomer with the inducible activity of the GAD65 monomer, likely following the trafficking
pathway of the GAD65 subunit, thus gaining access to the dynamic GAD65 palmitoylation/
depalmitoylation cycle. In neurons, the GAD67:GAD67 homodimer is a constitutively active
holoenzyme, capable of GABA synthesis not only in the cytosol but also in Golgi and vesicular
membranes, thereby providing the main supply of basal GABA levels for regulated secretion in
the course of inhibitory neurotransmission. In β-cells, however, the lack of flexible localization
of the GAD67:GAD67 homodimer suggests that it produces only cytosolic GABA. We propose
that cytosolic GABA produced by GAD67:GAD67 in β-cells can have multiple destinations
color, B) and to cytosolic vesicles that also harbor hGAD65-mCherry (orange color, indicated by arrows, C-E). Scale bars: 20 μm. (F) Correlation coefficient
analysis for co-localization of mGAD67-GFP with GM130 in singly (n = 12) and doubly (n = 7) transfected INS-1 cells. (G) Correlation coefficient analysis for
co-localization of mGAD67-GFP and hGAD65-mCherry in Golgi region (n = 11) and cytosolic vesicles of doubly transfected INS-1 cells (n = 23). Results are
presented as mean ± S.E. ***P< 0.0001.
doi:10.1371/journal.pone.0117130.g007
Fig 8. Schematic model of synthesis by and trafficking of GAD-dimers in β-cells and neurons. Three different dimers synthesize GABA in β-cells and
neurons. Homodimers of GAD65, transiently activated by influx of PLP, traffic between the cytosolic face of TGN and peripheral vesicles in β-cells and
synaptic vesicles in neurons. The anterograde trafficking from TGN is dependent on palmitoylation of cysteines 30 and 45 [19]. Depalmitoylation of the
protein results in axonal retrograde transport back to the Golgi compartment [12]. Newly synthesized GABA produced by this dimer, may deliver GAD65
directly onto a vesicular GABA transporter for rapid accumulation and secretion. The GAD67:GAD65 heterodimer, consisting of one constitutively active
GAD67 subunit and one conditionally active GAD65 subunit transiently activated by an influx of PLP, can be targeted to TGN and peripheral vesicles/
presynaptic clusters through the membrane anchoring moiety of GAD65 [22] and perhaps also cycle between the TGN and peripheral vesicles via the
palmitoylation/depalmitoylation cycle of GAD65. It is unknown whether GABA produced by GAD67 in this heterodimer, can be directly loaded onto a
vesicular GABA transporter associated with GAD65, or whether it is first released into the cytosol. In neurons, the constitutively active GAD67:GAD67
homodimers, are anchored to membranes and target to Golgi and synaptic vesicle membranes by a GAD65 independent mechanism [23]. In β-cells,
however, the GAD67 homodimers are, however, soluble and produce GABA released into the cytosol. Three possible fates can be suggested for GABA
produced by this dimer. It could be secreted by a reverse orientation of the plasmamembrane GABA transporter GAT3, transported to and taken up by
secretory vesicles by an unknownmechanism, or metabolized in the GABA-shunt.
doi:10.1371/journal.pone.0117130.g008
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and functions, including: i) release to the islet interstitium by a non-vesicular mechanism to
produce tonic rather than phasic signaling through highly sensitive GABAA receptors reported
in islets [58]; ii) transport to and uptake by secretory vesicles for regulated secretion; iii) serve
as a β-cell growth factor [31] perhaps secreted by a reverse action of GATs as described for neu-
rons [59]; and iv) providing a source of energy through metabolizing in the GABA shunt [28].
Because of the species differences in β-cell GAD-isoform expression [25], it would appear that
mouse islets only express the GAD67 homodimer, human islets only the GAD65 homodimer,
while rat islets express all three dimers. Future studies of GABA secretion and function in islets
of mouse, human and rat, may address the possibility that each GAD-isoform and each GAD-
dimer is involved preferentially in a specific mode of GABA release and/or function in islet
cells, and, therefore, that there may be subtle but important physiological differences in the
roles of GABA biosynthesis in islet β-cells of the three species.
Supporting Information
S1 Fig. The GAD65-independent mechanism of GAD67 membrane anchoring is functional
in COS-7 cells, CHO cells, and rat hippocampal neurons. Projected confocal images of a
COS-7 cell (A), CHO cell (B), and rat hippocampal neurons (C-E) transiently expressing
GAD67-GFP. COS-7 and CHO cells were fixed 24 h following transfection. Rat hippocampal
neurons were transfected at DIV 6 and fixed 72 h following transfection. (A-C) Cells were
immunostained for GFP (green) and the Golgi marker GM130 (red). GAD67-GFP is targeted
to Golgi membranes and cytosolic vesicles (A-C, enlarged frames) in COS-7 cells (A), CHO
cells (B), and rat hippocampal neurons (C). (D-E) Rat hippocampal neurons were triple immu-
nostained for GFP (green), synaptophysin (red), and endogenous GAD65 (GAD6 antibody,
blue). The transfected neuron is a non-GABAergic neuron devoid of endogenous GAD65.
However, GAD65 is seen in the cell body and axonal puncta of a neighboring GABAergic neu-
ron (blue). Human GAD67-GFP colocalizes with synaptophysin in presynaptic clusters (ar-
rowheads, enlarged frame), which are devoid of GAD65. Endogenous GAD65 colocalizes with
synaptophysin in presynaptic clusters of the non-transfected GABAergic neuron in the same
field of view (arrows, enlarged frame). Scale bars: 10 μm.
(TIF)
S2 Fig. GAD65-GFP-containing vesicles in INS-1 cells are distinct from the insulin-con-
taining large dense core secretory vesicles. Projected confocal images of INS-1 cells singly
transfected with hGAD65-GFP and immunostained for GFP (green), endogenous insulin (red)
and the nuclear stain DAPI (blue). GAD65-GFP-containing vesicles do not co-localize with in-
sulin-containing large dense core vesicles (enlarged frame). Scale bar: 10 μm.
(TIF)
S3 Fig. Endogenous GAD65 in human pancreatic β-cells is primarily targeted to the Golgi
compartment and to vesicles distinct from insulin secretory vesicles. Projected confocal im-
ages of human islet single cells imaged at 40nm per pixel resolution (A) or 100 nm per pixel
resolution (B) and immunostained for endogenous GAD65 (green, GAD6 antibody), insulin
(magenta), the Golgi marker protein giantin (red), and the nuclear stain DAPI (blue). In
human islet single cells, GAD65 is expressed in Golgi membranes (enlarged frames, lower left
panels) and cytosolic vesicles that are distinct from insulin containing vesicles (enlarged
frames, lower middle panels). Scale bar: 10 μm.
(TIF)
S4 Fig. Expression of GAD65 in rat islet cells is restricted to insulin positive β-cells and not
detected in glucagon-positive α-cells. Projected confocal images of rat islet single cells
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immunostained for endogenous GAD65 (GAD6 antibody, green), insulin (red), and glucagon
(magenta). GAD65 expression is confined to insulin positive β-cells (red) and not detected in
the glucagon-positive α-cell (magenta). The arrowhead indicates an insulin positive cell that is
GAD65 negative. Scale bar: 10 μm.
(TIF)
S5 Fig. NAP22 is expressed in rat islets, rat brain and INS-1 cells. Immunoblotting analysis
of endogenous expression of NAP22 in lysates of rat islets (lane 1), rat brain homogenate (lane
2) and INS-1 cells (lane 3). Equal amounts of protein (10 μg) were loaded in each lane. NAP22
is expressed in all three cell types/tissues.
(TIF)
S6 Fig. Confocal analyses of NAP22 expression and subcellular distribution in INS-1 cells,
rat islets cells, and neurons reveal minor or no colocalization with GAD67 and GAD65. (A)
Projected confocal images of INS-1 cells singly transfected with mGAD67-GFP and immunos-
tained for GFP (green) and NAP22 (red). (B) Projected confocal images of rat pancreatic islet
cells immunostained for endogenous GAD65 (GAD6 antibody, green) and NAP22 (red). In
both cell types, NAP22 is mainly detected in the plasma membrane and colocalization
between NAP22 and either GAD67 or GAD65 GAD is either non-existent or minimal. Scale
bar: 10 μm. (C) Projected confocal images of hippocampal neurons immunostained for NAP22
(NAP22 antibody, red) and endogenous GAD65 (GAD6 antibody, green). In some axonal
areas, no colocalization between NAP22 and GAD65 is detected (enlarged frame a), while is
other axonal areas, co-localization between NAP22 and GAD65 is observed in a small fraction
of axonal boutons (enlarged frame b). Scale bar: 30 μm (C) and 10 μm (a and b).
(TIFF)
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